Macrolide use shortens fever duration in Mycoplasma pneumoniae infection in children: a 2-year experience

Related Experiment Videos

Ying-Jen Lu1, Tou-Hwei Chen, Lung-Huang Lin

  • 1Department of Pediatrics, Cathay General Hospital, Taipei, Taiwan.

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|September 13, 2008
PubMed
Abstract

Insights

Macrolide treatment for Mycoplasma pneumoniae infection in children significantly reduces fever duration. This study highlights the effectiveness of macrolides in managing pediatric respiratory infections caused by this common pathogen.

Area of Science:

  • Pediatric infectious diseases
  • Respiratory medicine
  • Microbiology

Background:

  • Mycoplasma pneumoniae is a leading cause of community-acquired respiratory tract infections in children.
  • Understanding treatment outcomes is crucial for managing pediatric respiratory illnesses.

Purpose of the Study:

  • To evaluate clinical and demographic data of children with Mycoplasma pneumoniae infection.
  • To compare outcomes in children with and without macrolide treatment.

Main Methods:

  • Retrospective study of 139 pediatric patients with Mycoplasma pneumoniae infection.
  • Patients were divided into groups based on macrolide therapy (azithromycin or erythromycin) during hospitalization.
  • Demographic, clinical, and laboratory characteristics were analyzed.

Main Results:

  • Fever and cough were the most frequent symptoms.
  • No significant difference in fever subsidence time between azithromycin and erythromycin.
  • Children not receiving macrolides experienced significantly longer fever duration.

Conclusions:

  • Macrolide therapy effectively shortens the duration of fever in children with Mycoplasma pneumoniae infection.
  • Early macrolide administration may improve clinical outcomes for pediatric patients.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...